Autonomix Medical (AMIX) CFO Trent N. Smith Receives 15,000-Share Award

What Happened

• Trent N. Smith, Chief Financial Officer of Autonomix Medical, was granted 15,000 shares as a restricted stock award (transaction code A) on September 3, 2026. No purchase price or immediate cash value is reported in the filing (price listed as N/A). This was a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-03 (reported on Form 4 filed 2026-09-21; accession 0001437749-26-030774).
• Transaction type/code: Award/Grant (A).
• Shares involved: 15,000 restricted shares; price: N/A (award).
• Vesting: Footnote indicates the restricted shares vest one year from issuance — on September 3, 2027.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Timeliness: The Form 4 was filed 18 days after the transaction date and appears to be late (SEC generally requires Form 4 within two business days); late filing can limit prompt public transparency but does not itself indicate the nature of the award.

Context

• Restricted stock awards are a common form of executive compensation and typically vest over time; they are not an open-market purchase (which some investors view as a stronger bullish signal).
• Because this is a compensation grant, it should be interpreted as part of pay/retention arrangements rather than an immediate endorsement of the stock by the insider.